Advertisement
Advertisement

PSTV

PSTV logo

PLUS THERAPEUTICS, Inc. Common Stock

3.96
USD
Sponsored
-0.12
-2.94%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

3.97

+0.01
+0.25%

PLUS THERAPEUTICS, Inc. Common Stock Profile

About

Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.

Info & Links

CEO

Marc H. Hedrick

Headquarters

6420 LEVIT GREEN BOULEVARD, SUITE 310
HOUSTON, TX 77021, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.plustherapeutics.com

Auditor

BDO USA P.C.

Share holders

25

Employees

28

PLUS THERAPEUTICS, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

27.33M

Enterprise Value

24.97M

Enterprise Value/EBITDA(ttm)

-1.35

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

5.16

Price to Book(mrq)

5.45

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-254.04%

Profit Margin(ttm)

-501.78%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

12.90%

Return on Assets(ttm)

-92.28%

Income Statement

Revenue(ttm)

5.18M

Revenue Per Share(ttm)

0.75

Gross Profit(ttm)

5.18M

EBITDA(ttm)3

-18.49M

Net Income Available to Common(ttm)

-11.93M

Diluted EPS(ttm)

-31.00

Share Statistics

Beta (5Y Monthly)

1.03

52-Week Change

-14.05%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

6.88M

Dividend Yield

0.00%

Float4

6.81M

% Held by Insiders

0.79%

% Held by Institutions

3.28%

Balance Sheet

Total Cash(mrq)

15.11M

Total Cash Per Share(mrq)

2.20

Total Debt(mrq)

667.00K

Total Debt/Equity(mrq)

18.77%

Current Ratio(mrq)

1.23%

Quick Ratio(mrq)

1.23%

Book Value Per Share(mrq)

0.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.27

Free Cash Flow(ytd)

-20.81M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement